46 results on '"Montine, Thomas J"'
Search Results
2. Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study
3. Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
4. Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
5. Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment
6. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology1
7. Hallucinations and Development of Dementia in Parkinson’s Disease
8. Cognitive Performance in Parkinson’s Disease in the Brain Health Registry
9. TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study
10. Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort
11. Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex
12. Neuropathological Comparison of Adult Onset and Juvenile Huntington’s Disease with Cerebellar Atrophy: A Report of a Father and Son
13. Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study
14. Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort
15. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
16. Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.
17. Increased CSF E-Selectin in Clinical Alzheimer’s Disease without Altered CSF Aβ 42 and Tau
18. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ42 using Meso Scale Discovery Assays for Alzheimer's Disease
19. Neuropathologic Correlates of Cognition in a Population-Based Sample
20. Pacific Northwest Udall Center of Excellence Clinical Consortium: Study Design and Baseline Cohort Characteristics
21. Anatomic and Clinical Pathology of Cognitive Impairment and Dementia
22. High-Intensity Physical Activity Modulates Diet Effects on Cerebrospinal Amyloid-β Levels in Normal Aging and Mild Cognitive Impairment
23. Treatment with a γ-Ketoaldehyde Scavenger Prevents Working Memory Deficits in hApoE4 Mice
24. Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia
25. Neuropathology in the Adult Changes in Thought Study: A Review
26. Mitochondrial Effects of Lipid-Derived Neurotoxins
27. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau.
28. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
29. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders
30. Lewy body pathology in late-onset familial Alzheimer's disease: A clinicopathological case series
31. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease
32. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases
33. Biomarkers for Alzheimer's disease
34. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease
35. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease
36. Advanced glycation endproduct precursor alters intracellular amyloid- β/AβPP carboxy-terminal fragment aggregation and cytotoxicity
37. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration
38. Anatomic and Clinical Pathology of Cognitive Impairment and Dementia.
39. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease.
40. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases.
41. Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive impairment.
42. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.
43. Advanced glycation endproduct precursor alters intracellular amyloid- β/AβPP carboxy-terminal fragment aggregation and cytotoxicity.
44. Biomarkers for Alzheimer's disease.
45. Neurodegeneration: The molecular pathology of dementia and movement disorders, by Dennis Dickson ed.
46. Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.